News
- Author:
- Susan London
Publish date: September 5, 2013
Major finding: Women who received MRI in addition to conventional imaging did not have a lower 5-year rate of locoregional recurrence when compare...
News
- Author:
- Susan London
Publish date: September 5, 2013
Major Finding: Overall, 44.7% of women underestimated their risk and 45.9% overestimated their risk, while just 9.4% gave an accurate estimate.Dat...
News
- Author:
- Susan London
Publish date: September 5, 2013
Major Finding: Overall, 44.7% of women underestimated their risk and 45.9% overestimated their risk, while just 9.4% gave an accurate estimate.Dat...
News
- Author:
- Susan London
Publish date: September 4, 2013
Major finding: The rate of CVD diagnosis did not differ between patients treated with surgery alone and patients treated with surgery plus radiati...
Article
- Author:
- Susan London
Publish date: September 4, 2013
News
- Author:
- Susan London
Publish date: August 6, 2013
Major finding: The combination of the number of PMCH- and NAMPT-expressing cells in the interfollicular area plus the interfollicular-to-intrafolli...
News
- Author:
- Susan London
Publish date: August 6, 2013
Major finding: Compared with counterparts having scores that put them into the IPSS-R intermediate-risk group, patients having scores that put the...
News
- Author:
- Susan London
Publish date: July 31, 2013
Major finding: Among the subset treated with modern clinical practices, African American men were more likely than white men and other men combine...
News
- Author:
- Susan London
Publish date: July 24, 2013
Major finding: Compared with patients managed with usual wound care, patients managed with incisional negative-pressure wound therapy were 68% les...
News
- Author:
- Susan London
Publish date: July 22, 2013
Major Finding: Everolimus decreased the risk of progression or death by 73% in patients whose tumors had none or one genetic alteration in the mos...
News
- Author:
- Susan London
Publish date: July 22, 2013
Major finding: Adding upamostat vs. placebo did not significantly prolong progression-free survival in the entire trial population (8.3 vs. 7.5 mo...
News
- Author:
- Susan London
Publish date: July 12, 2013
Major finding: Compared with placebo, everolimus led to better progression-free survival when added to trastuzumab and vinorelbine (hazard ratio, ...
News
- Author:
- Susan London
Publish date: July 11, 2013
Major finding: Among patients with one positive node, those falling into the ROR low-risk group (41% of the one-node subset) and those having the ...
News
- Author:
- Susan London
Publish date: July 10, 2013
Major finding: Compared with high-dose dexamethasone, pomalidomide plus low-dose dexamethasone yielded better median progression-free survival (4....
News
- Author:
- Susan London
Publish date: July 9, 2013
Major finding: Compared with radical resection, local resection was associated with a lower risk of perioperative mortality (rate ratio, 0.31), wi...
